This UK share has hiked dividends for 32 years – now its price has crashed 30%

Harvey Jones is tempted by a FTSE 100 stock with a stellar track record of dividend hikes. But he wonders why its share price is doing so badly.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

Image source: Getty Images

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Any UK share that can hike its dividend for 32 years in a row demands my attention. A high yield is all very well, but one that rises every year can be even better.

It indicates that the company is on a steady course, with the board confident enough to keep paying shareholders more. Yet it doesn’t necessarily mean that all is well.

Chemicals manufacturer Croda International (LSE: CRDA) is a true Dividend Aristocrat. Yet investors have gone off it lately, and with good reason.

FTSE 100 income hero

The Croda share price has had a nightmare. It’s crashed 30.78% over the last year. Over three years, it’s down 48.25%.

Croda had a good pandemic with panicky customers stockpiling chemicals and vaccine makers relying on its lipids. The aftermath has been brutal as lipid sales plunged and customers embarked on a “prolonged destocking”.

Full-year 2023 pro-forma sales, published in February, fell 11% as customers reduced inventory levels across multiple markets. Adjusted profit before tax crashed 33% to £308.8m. The share price duly followed.

Happily, the dividend didn’t. The board maintained its three-decade record of dividend progression but only just, hiking the full-year payout a measly 1p. That lifted it from 108p per share to 109p, a rise of just 0.93%.

Croda’s shares don’t look like they’re about to make a stellar comeback in 2024, judging by Q1 results. Group sales fell 10% to £409m, albeit versus a strong Q1 2023 comparator. Full-year profits before tax remain on course to be between £260m and £300m. Last year they rocked in at £236.3m, so there’s progress there.

Chief executive Steve Foots said the Consumer Care division made an encouraging start to the year, particularly in North America, but Life Sciences face a challenging market, particularly in Crop Protection.

Low yield, low growth

The dividend should be solid with free cash flow rising 5% to £165.5m last year, but I suspect investors are in line for another marginal hike. The trailing yield of 2.68% is forecast to edge up to 2.75% in 2024 and 2.8% in 2025. That’s pretty sluggish.

Net debt jumped to £537.6m in 2023 following the recent Solus Biotech acquisition but is forecast to fall to £503m in 2024 and £478m in 2025. Given that Croda is a £5.68bn company, I’m not worried by that.

Normally when a stock has crashed, I expect its price-to-earnings ratio to follow. Sadly, that’s not the case here, because earnings have fallen sharply too, from £2.089bn in 2022 to £1.654bn in 2024. Today’s P/E has jumped to 33.49 times as a result. Let’s see what the chart shows.


Chart by TradingView

Croda’s shares are expensive, rather than the bargain I hoped to find. As the pandemic effect fades, the company should start to grow from today’s lower base. If the economy picks up, demand for its products could accelerate. Croda could make a good long-term buy-and-hold, but I’m not excited enough to purchase it at today’s price. I can see far better FTSE 100 dividend-paying bargains out there.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Harvey Jones has no position in any of the shares mentioned. The Motley Fool UK has recommended Croda International Plc. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing For Beginners

Here’s what the Trump auto tariffs could mean for the UK stock market

Jon Smith explains the implications of fresh auto tariffs on the stock market and flags up a UK share that…

Read more »

Investing Articles

Record £1bn profit gives the Next share price a boost. Is it still cheap?

The Next share price has been soaring ahead of sector rivals, and the latest full-year results might just give us…

Read more »

Midnight is celebrated along the River Thames in London with a spectacular and colourful firework display.
Investing Articles

Up 16% in a day on a thrilling new forecast – can this FTSE 250 stock make investors rich again?

Harvey Jones was delighted yesterday when FTSE 250 grocery chain Ocado Group rocketed on a positive broker update. Can investors…

Read more »

Investing Articles

£10,000 invested in Tesla stock just 1 week ago is now worth…

Tesla stock has long defied logic. So despite its seemingly extreme valuation, should I hold my nose and just buy…

Read more »

Long-term vs short-term investing concept on a staircase
Investing Articles

Down 44% from its 12-month high, is this FTSE 250 fast-food favourite an irresistible bargain to me now?

This FTSE 250 food retailer has tumbled this year, so its share price may be seriously undervalued. To find out…

Read more »

Investing Articles

Where’s the S&P 500 headed in 2025? Here’s what the experts have to say

Our writer consults a wide range of market experts to get an idea of where the S&P 500 might be…

Read more »

Investing Articles

If an investor put £10,000 in Barclays and Lloyds shares 3 months ago here’s what they’d have now… 

Harvey Jones has been doing very nicely out of his Lloyds shares, but not as nicely as Barclays investors have…

Read more »

Investing Articles

£20k inheritance? Don’t blow it: target a second income that pays £1k a month!

Our writer reveals a strategic way to target an attractive second income by investing savings or inheritance money in the…

Read more »